Month

May 2015
FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood [ 05-15-2015 ]The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin may lead to ketoacidosis, a serious condition where the body produces high levels of […]
Read More
COVID-19 UPDATE: Your health and safety are of the utmost importance to us. But we also know that your legal issues can’t wait.Learn More >>